Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions
Abstract
Molecular farming in plants is an emerging platform for the production of pharmaceutical proteins, and host species such as tobacco are now becoming competitive with commercially established production hosts based on bacteria and mammalian cell lines. The range of recombinant therapeutic proteins produced in plants includes replacement enzymes, vaccines and monoclonal antibodies (mAbs). But plants can also be used to manufacture toxins, such as...
Paper Details
Title
Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions
Published Date
Mar 1, 2021
Journal
Volume
47
Pages
107683 - 107683
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History